| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $0.9B | $1.4B | $0.7B | $0.8B | $1.1B | $1.0B | $1.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.4B | $0.7B | $0.1B | $0.4B | $0.4B | $0.1B | $0.1B |
| EPS (Basic) | $10.39 | $7.01 | $12.54 | $1.95 | $5.29 | $4.22 | $1.43 | $0.84 |
| EPS (Diluted) | $10.26 | $6.87 | $12.30 | $1.92 | $5.23 | $4.19 | $1.42 | $0.83 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.2B | $11.9B | $12.5B | $16.8B | $18.2B | $15.3B | $14.3B | $13.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $6.4B | $6.3B | $6.8B | $11.6B | $11.7B | $8.6B | $7.7B | $7.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.7B | $5.5B | $5.7B | $5.1B | $6.3B | $6.6B | $6.6B | $6.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.0B | $0.5B | $-2.5B | $-1.9B | $-0.9B | $-0.5B | $0.5B |
| Investing Cash Flow | $0.6B | $0.8B | $0.3B | $1.7B | $0.0B | $0.8B | $1.2B | $0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.6B | $-1.0B | $-0.7B | $0.6B | $2.0B | $0.2B | $-0.6B | $-0.8B |